Global Drug Based on Gene Therapy Market Research Report 2024(Status and Outlook)
Report Overview:
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The Global Drug Based on Gene Therapy Market Size was estimated at USD 2114.22 million in 2023 and is projected to reach USD 9082.63 million by 2029, exhibiting a CAGR of 27.50% during the forecast period.
This report provides a deep insight into the global Drug Based on Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Based on Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Based on Gene Therapy market in any manner.
Global Drug Based on Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Gene Therapy
Non-viral Gene Therapy
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug Based on Gene Therapy Market
- Overview of the regional outlook of the Drug Based on Gene Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Based on Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Drug Based on Gene Therapy
- 1.2 Key Market Segments
- 1.2.1 Drug Based on Gene Therapy Segment by Type
- 1.2.2 Drug Based on Gene Therapy Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Drug Based on Gene Therapy Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Drug Based on Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Drug Based on Gene Therapy Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Drug Based on Gene Therapy Market Competitive Landscape
- 3.1 Global Drug Based on Gene Therapy Sales by Manufacturers (2019-2024)
- 3.2 Global Drug Based on Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Drug Based on Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Drug Based on Gene Therapy Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Drug Based on Gene Therapy Sales Sites, Area Served, Product Type
- 3.6 Drug Based on Gene Therapy Market Competitive Situation and Trends
- 3.6.1 Drug Based on Gene Therapy Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Drug Based on Gene Therapy Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Drug Based on Gene Therapy Industry Chain Analysis
- 4.1 Drug Based on Gene Therapy Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Drug Based on Gene Therapy Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Drug Based on Gene Therapy Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Drug Based on Gene Therapy Sales Market Share by Type (2019-2024)
- 6.3 Global Drug Based on Gene Therapy Market Size Market Share by Type (2019-2024)
- 6.4 Global Drug Based on Gene Therapy Price by Type (2019-2024)
- 7 Drug Based on Gene Therapy Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Drug Based on Gene Therapy Market Sales by Application (2019-2024)
- 7.3 Global Drug Based on Gene Therapy Market Size (M USD) by Application (2019-2024)
- 7.4 Global Drug Based on Gene Therapy Sales Growth Rate by Application (2019-2024)
- 8 Drug Based on Gene Therapy Market Segmentation by Region
- 8.1 Global Drug Based on Gene Therapy Sales by Region
- 8.1.1 Global Drug Based on Gene Therapy Sales by Region
- 8.1.2 Global Drug Based on Gene Therapy Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Drug Based on Gene Therapy Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Drug Based on Gene Therapy Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Drug Based on Gene Therapy Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Drug Based on Gene Therapy Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Drug Based on Gene Therapy Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Biogen
- 9.1.1 Biogen Drug Based on Gene Therapy Basic Information
- 9.1.2 Biogen Drug Based on Gene Therapy Product Overview
- 9.1.3 Biogen Drug Based on Gene Therapy Product Market Performance
- 9.1.4 Biogen Business Overview
- 9.1.5 Biogen Drug Based on Gene Therapy SWOT Analysis
- 9.1.6 Biogen Recent Developments
- 9.2 Novartis
- 9.2.1 Novartis Drug Based on Gene Therapy Basic Information
- 9.2.2 Novartis Drug Based on Gene Therapy Product Overview
- 9.2.3 Novartis Drug Based on Gene Therapy Product Market Performance
- 9.2.4 Novartis Business Overview
- 9.2.5 Novartis Drug Based on Gene Therapy SWOT Analysis
- 9.2.6 Novartis Recent Developments
- 9.3 Gilead Sciences
- 9.3.1 Gilead Sciences Drug Based on Gene Therapy Basic Information
- 9.3.2 Gilead Sciences Drug Based on Gene Therapy Product Overview
- 9.3.3 Gilead Sciences Drug Based on Gene Therapy Product Market Performance
- 9.3.4 Gilead Sciences Drug Based on Gene Therapy SWOT Analysis
- 9.3.5 Gilead Sciences Business Overview
- 9.3.6 Gilead Sciences Recent Developments
- 9.4 Sarepta Therapeutics
- 9.4.1 Sarepta Therapeutics Drug Based on Gene Therapy Basic Information
- 9.4.2 Sarepta Therapeutics Drug Based on Gene Therapy Product Overview
- 9.4.3 Sarepta Therapeutics Drug Based on Gene Therapy Product Market Performance
- 9.4.4 Sarepta Therapeutics Business Overview
- 9.4.5 Sarepta Therapeutics Recent Developments
- 9.5 Alnylam Pharmaceuticals
- 9.5.1 Alnylam Pharmaceuticals Drug Based on Gene Therapy Basic Information
- 9.5.2 Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Overview
- 9.5.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Market Performance
- 9.5.4 Alnylam Pharmaceuticals Business Overview
- 9.5.5 Alnylam Pharmaceuticals Recent Developments
- 9.6 Amgen
- 9.6.1 Amgen Drug Based on Gene Therapy Basic Information
- 9.6.2 Amgen Drug Based on Gene Therapy Product Overview
- 9.6.3 Amgen Drug Based on Gene Therapy Product Market Performance
- 9.6.4 Amgen Business Overview
- 9.6.5 Amgen Recent Developments
- 9.7 Spark Therapeutics
- 9.7.1 Spark Therapeutics Drug Based on Gene Therapy Basic Information
- 9.7.2 Spark Therapeutics Drug Based on Gene Therapy Product Overview
- 9.7.3 Spark Therapeutics Drug Based on Gene Therapy Product Market Performance
- 9.7.4 Spark Therapeutics Business Overview
- 9.7.5 Spark Therapeutics Recent Developments
- 9.8 Akcea Therapeutics
- 9.8.1 Akcea Therapeutics Drug Based on Gene Therapy Basic Information
- 9.8.2 Akcea Therapeutics Drug Based on Gene Therapy Product Overview
- 9.8.3 Akcea Therapeutics Drug Based on Gene Therapy Product Market Performance
- 9.8.4 Akcea Therapeutics Business Overview
- 9.8.5 Akcea Therapeutics Recent Developments
- 9.9 bluebird bio
- 9.9.1 bluebird bio Drug Based on Gene Therapy Basic Information
- 9.9.2 bluebird bio Drug Based on Gene Therapy Product Overview
- 9.9.3 bluebird bio Drug Based on Gene Therapy Product Market Performance
- 9.9.4 bluebird bio Business Overview
- 9.9.5 bluebird bio Recent Developments
- 9.10 Sunway Biotech
- 9.10.1 Sunway Biotech Drug Based on Gene Therapy Basic Information
- 9.10.2 Sunway Biotech Drug Based on Gene Therapy Product Overview
- 9.10.3 Sunway Biotech Drug Based on Gene Therapy Product Market Performance
- 9.10.4 Sunway Biotech Business Overview
- 9.10.5 Sunway Biotech Recent Developments
- 9.11 SIBIONO
- 9.11.1 SIBIONO Drug Based on Gene Therapy Basic Information
- 9.11.2 SIBIONO Drug Based on Gene Therapy Product Overview
- 9.11.3 SIBIONO Drug Based on Gene Therapy Product Market Performance
- 9.11.4 SIBIONO Business Overview
- 9.11.5 SIBIONO Recent Developments
- 9.12 AnGes
- 9.12.1 AnGes Drug Based on Gene Therapy Basic Information
- 9.12.2 AnGes Drug Based on Gene Therapy Product Overview
- 9.12.3 AnGes Drug Based on Gene Therapy Product Market Performance
- 9.12.4 AnGes Business Overview
- 9.12.5 AnGes Recent Developments
- 9.13 Orchard Therapeutics
- 9.13.1 Orchard Therapeutics Drug Based on Gene Therapy Basic Information
- 9.13.2 Orchard Therapeutics Drug Based on Gene Therapy Product Overview
- 9.13.3 Orchard Therapeutics Drug Based on Gene Therapy Product Market Performance
- 9.13.4 Orchard Therapeutics Business Overview
- 9.13.5 Orchard Therapeutics Recent Developments
- 9.14 Human Stem Cells Institute
- 9.14.1 Human Stem Cells Institute Drug Based on Gene Therapy Basic Information
- 9.14.2 Human Stem Cells Institute Drug Based on Gene Therapy Product Overview
- 9.14.3 Human Stem Cells Institute Drug Based on Gene Therapy Product Market Performance
- 9.14.4 Human Stem Cells Institute Business Overview
- 9.14.5 Human Stem Cells Institute Recent Developments
- 10 Drug Based on Gene Therapy Market Forecast by Region
- 10.1 Global Drug Based on Gene Therapy Market Size Forecast
- 10.2 Global Drug Based on Gene Therapy Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Drug Based on Gene Therapy Market Size Forecast by Country
- 10.2.3 Asia Pacific Drug Based on Gene Therapy Market Size Forecast by Region
- 10.2.4 South America Drug Based on Gene Therapy Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Drug Based on Gene Therapy by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Drug Based on Gene Therapy Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Drug Based on Gene Therapy by Type (2025-2030)
- 11.1.2 Global Drug Based on Gene Therapy Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Drug Based on Gene Therapy by Type (2025-2030)
- 11.2 Global Drug Based on Gene Therapy Market Forecast by Application (2025-2030)
- 11.2.1 Global Drug Based on Gene Therapy Sales (Kilotons) Forecast by Application
- 11.2.2 Global Drug Based on Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook